Skip to main content
. 2016 Aug 30;7(41):67612–67625. doi: 10.18632/oncotarget.11701

Table 2. Predicted hallmarks and modes of biological interaction.

Partner 1 Partner 2 Direct binding Linear pathway Convergence
Genome instability hallmark
OGG1 XRCC1 Synergistic and Co-suppressivea
PARP1 XRCC1 Synergistic
XPA XPC Synergistic
TP53 MDM2 Synergistic
TGFBR1 SMAD7 Suppressiveb
MUTYH OGG1 Synergistic
MUTYH XRCC1 Synergistic
ADH1B ALDH2 Synergistic
NQO1 NQO2 Synergistic
CYP1A1 CYP2E1 Synergistic
GSTT1 APEX1 Redundant
GSTT1/GSTM1 APEX1 Suppressive
GSTM1 NAT2 Redundant
Proliferation hallmark
RPS6KB1 PRKAG2 Synergistic
RPS6KB1 PIK3CA Suppressive
CDKN1B CHEK2 Synergistic
Multiple hallmarksc
MMP2 PARP1 Suppressive
a

An OGG1 SNP showed a synergistic interaction with p.Arg399Gln SNP (rs25487) but a co-suppressive interaction with p.Arg194Trp SNP (rs1799782) of XRCC1 [9].

b

The interaction was suppressive with the adjusted ORcombined, but redundant with the crude ORcombined [69].

c

Multiple hallmarks include inflammation, proliferation, insensitivity, resistance, immortality and angiogenesis for MMP2, and mutation for PARP1.